[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2005, 31(1) 61-63 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||
��������ͷ��������Ⱦ�����в�ѧ�о���չ | |||||||||||||||||||||||||||||||||||||||||||||||
����, ���� | |||||||||||||||||||||||||||||||||||||||||||||||
�����е�������ҽԺƤ���� 310009 | |||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
����ͷ��������Ⱦ����Ⱥ��ʮ���ձ�,����Ů�Ը�Ⱦ���о��ܶࡣ���������Ը�Ⱦ��֢״������,�Ҳ��������ϸ��,��˶���������ͷ��������Ⱦ���о����١����ŷ�������ѧ�����㷺��Ӧ��������ͷ�������ļ������в�ѧ����,ʹ���Ƕ�����������ͷ�������ĸ�Ⱦ���˽�һ������ʶ���ͽ�������������ͷ��������Ⱦ�����в�ѧ�о���չ������������ | |||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� ������ͷ״������,�� ���� ���в�ѧ | |||||||||||||||||||||||||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||||||||||||||||||||||||
Keywords: | |||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2004-04-07 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ:
�㽭ʡ���������мƻ�����������Ŀ(20040689) | |||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||
[1] Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol, 2000, 38:357. [2] Dillner J. The serological response to papillomaviruses. Semin Cancer Biol, 1999, 9:423-430. [3] Marais DJ, Rose RC, Lane C, et al. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia. J Med Virol, 2000, 60:403-410. [4] Hopfl R, Petter A, Thaler P,et al. High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men:a serological study. BMC Infect Dis, 2003,3:6. [5] Baldwin SB, Wallace DR, Papenfuss MR, et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis, 2003, 187:1064-1070. [6] Svare EI, Kjaer SK, Worm AM, et al. Risk factors for genital HPV DNA in men resemble those found in women:a study of male attendees at a Danish STD clinic. Sex Transm Infect, 2002, 78:215-218. [7] Wikstrom A, Popescu C, Forslund O. Asymptomatic penile HPV infection:a prospective study. Iht J STD AIDS, 2000, 11:80-84. [8] Lazcano-Ponce E, Herrero R, Munoz N, et al. High prevalence of human papillomavirus infection in Mexican males:comparative studyof penile-urethral swabs and urine samples. Sex Transm Dis, 2001,28:277-280. [9] Castellsague X, Ghaffari A, Daniel RW, et al. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia:a study in Spain and Colombia. J Infect Dis,1997, 176:353-361. [10] Franceschi S, Castellsague X, Dal Maso L, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer, 2002, 86:705-711. [11] Van Doornum GJ, Prins M, Juffermans LH, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners:a prospective study. Genitourin Med, 1994, 70:240-246. [12] Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis,2002, 186:1396-1402. [13] Castellsague X, Bosch FX, Munoz N. The male role in cervical cancer. Salud Publica Mex, 2003,45 :S345-353. [14] Hillman RJ, Ryait BK, Botcherby M, et al. Human papillomavirus DNA in the urogenital tracts of men with gonorrhoea, penile warts or genital dermatoses. Genitourin Med, 1993, 69:187-192. [15] Pinto PA, Mellinger BC. HPV in the male patient. Urol Clin North Am, 1999, 26:797-807. [16] Yoneta A, Yamashita T, Jin HY, et al. Development of squamous cell carcinoma by two high-risk human papillomaviruses (HPVs), a novel HPV-67 and HPV-31 from bowenoid papulosis. Br J Dermatol, 2000, 143:604-608. [17] Ikenberg H, Gissmann L, Gross G, et al. Human papillomavirus type-16-related DNA in genital Bowens disease and in Bowenoid papulosis. Int J Cancer, 1983, 32:563-565. [18] Mitsuishi T, Sata T, Iwasaki T, et al. The detection of human papillomavirus 16 DNA in erythroplasia of Queyrat invading the urethra. Br J Dermatol, 1998, 138:188-189. [19] Wieland U, Jurk S, Weissenborn S, et al. Erythroplasia of queyrat:coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol, 2000, 115:396-401. [20] Dillner J, Meijer C J, yon Krogh G,et al. Epidemiology of human papillomavirus infection. Scand J Urol Nephrol Suppl, 2000, (205) :194-200. [21] Hemminki K, Dong C. Cancer in husbands of cervical cancer patients. Epidemiology, 2000, 11:347-349. [22] Frisch M, Fenger C, van den Brule A J, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res, 1999,59:753-757. |
|||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |